YCBD cbdMD Inc. Accounting Capitalization

Public company logo of cbdMD Corp (YCBD)

Serving as the primary valuation tool, this price chart demonstrates the price action of cbdMD, Inc. (YCBD), which is implementing ESG principles into its eco-product line and transitioning to biodegradable packaging. The current indicator stands at 0.01, although quotes are under pressure from aggressive price dumping and FDA regulatory uncertainty. The business relies on modern cannabidiol extraction to create science-based stress relief products.

YCBD cbdMD Book Capitalization (07/04/2022 - 10/27/2026)
Flagship merchandise of cbdmd.com

To minimize risks when establishing a long-term position, it is essential to compare the market price with the dynamics of net assets, as reflected by the book value of equity. Amid regulatory pressure in the US and cost-cutting measures at cbdMD, Inc. (YCBD), this metric allows for an assessment of the business's real intrinsic value, separating the company's fundamental stability from the volatility of the CBD consumer sector.

Competitor analysis for cbdMD, Inc.

HLN - Company Book Value|Book Capitalization Kenvue Inc.|VRNA (veronapharma.com) - Accounting Capitalization|Company Book Value Jyong Biotech MENS|Net Asset Value Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Book Capitalization|Accounting Value of Company Perrigo Corp (PRGO)|Book Capitalization ALVO (Alvotech)|liquidia.com - Book Capitalization|Company Book Value Galapagos (GLPG)|ANIP: Accounting Value of Company|MNKD (MannKind Corp.) - Company Book Value|Amphastar Corp (AMPH) - Company Net Assets|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Company Net Assets|Accounting Value of Company AQST (Aquestive Therapeutics Inc)|SCPH: Company Book Value|TECX - Total Stockholders' Equity|Company Net Assets Tonix Pharmaceuticals TNXP|SXTC - Total Net Assets|Book Capitalization eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Accounting Value of Company|Book Capitalization EXOZ (Invizyne Technologies, Inc.)|Total Stockholders' Equity ORMP|Entera Bio Ltd. (ENTX) - Company Book Value|Accounting Value of Company ipatherapeutics.com (HYFT)|ABVC BioPharma, Inc. - Book Capitalization|Company Net Assets Cumberland Pharmaceuticals Inc CPIX|QNTM - Book Capitalization|FGEN - Company Book Value|Book Capitalization Telomir Pharmaceuticals|RANI (Rani Therapeutics Holdings, Inc.) - Accounting Capitalization|Company Book Value SNYR|Company Net Assets Rallybio Corp.|Book Capitalization Lexaria Bioscience LEXX|Accounting Capitalization Pulmatrix Corporation PULM|Company Net Assets Pheton Holdings|Accounting Value of Company Aptorum Group Ltd APM|Book Capitalization LYRA (Lyra Therapeutics)|IBO: Book Valuation of Business|Company Book Value tnfpharma.com|PainReform Corp (PRFX) - Accounting Capitalization|Book Capitalization CYTO|Company Net Assets lipella.com (LIPO)|OPTN (OptiNose) - Company Net Assets|Book Valuation of Business Pieris Pharmaceuticals Inc PIRS|PROC: Company Net Assets|Total Stockholders' Equity Petros Pharma PTPI|QLI: Book Capitalization|SLRN - Company Net Assets|TFF Pharmaceuticals, Inc. (TFFP) - Book Capitalization